Live Chat

Trade Vir Biotechnology VIR

Magbenta
 Bumili

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Info

Spread

0.05

Spread (%)

0.6562 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Lunes

13:31 - 19:59

Martes

13:31-19:59

Miyerkules

13:31-19:59

Huwebes

13:31-19:59

Biyernes

13:31-19:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

1317845888

Natitirang Pagbabahagi

136706000

Petsa ng Mga Kita (Susunod)

0000-00-00

Pambayad si dividend

Araw ng Pag-alis ng Karapatan sa Dividend

Inaasahang Taunang Rate ng Dividend

0

Inaasahang Taunang Dividend Yield

0

EPS

-3.58

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Mga kaugnay na instrumento

Asset
Magbenta
Bumili
Change (%)

Mag-trade Ngayon

Mag-trade Ngayon

Mag-trade Ngayon

Mag-trade Ngayon
view_all_instruments

Mga pinakabagong balita

Manatiling updated sa mga pinakabagong balitang pinansyal mula sa buong mundo.

Miyerkules, 6 Nobyembre 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Martes, 5 Nobyembre 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Martes, 5 Nobyembre 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Martes, 5 Nobyembre 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Martes, 5 Nobyembre 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Martes, 5 Nobyembre 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Lunes, 4 Nobyembre 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Lunes, 4 Nobyembre 2024

US election: What will happen to tesla stock if Trump wins?

Tingnan ang lahat ng mga Balita
Trustpilot
Live Chat